Thrombus-targeted nanocarrier attenuates bleeding complications associated with conventional thrombolytic therapy.
Saved in:
| Title: | Thrombus-targeted nanocarrier attenuates bleeding complications associated with conventional thrombolytic therapy. |
|---|---|
| Authors: | Absar S; Department of Pharmaceutical Sciences, Texas Tech University Health Sciences Center, 1300 Coulter St., Amarillo, Texas 79106, USA., Nahar K, Kwon YM, Ahsan F |
| Source: | Pharmaceutical research [Pharm Res] 2013 Jun; Vol. 30 (6), pp. 1663-76. Date of Electronic Publication: 2013 Mar 07. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Kluwer Academic/Plenum Publishers Country of Publication: United States NLM ID: 8406521 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-904X (Electronic) Linking ISSN: 07248741 NLM ISO Abbreviation: Pharm Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
